Kasim Allel

PhD Infectious Diseases @LSHTM, MSc Health Economics @UCL. Researcher University of Oxford @HERC. ID epidemiologist🦠, Global health advocate🌍 #AMR📈🇨🇱

[Kasim Allel @kasim_allel]

We found bidirectional associations between animal/humans’ antibiotic consumption and AMR rates in humans/animals, respectively. We also suggested significant roles of socioeconomics, including governance on AMR rates in humans and animals.

[IDDjobs: infectious disease dynamics jobs @IDDjobs]

CLOSING SOON: Postdoc (Oxford, UK)
Modelling the health-economic impact of different interventions aimed at reducing antimicrobial resistance (AMR)
with @kb_pouwels @kasim_allel
at University of Oxford
More details: https://t.co/QPbrwZzf0B

[María José @PepaHodl]

Today in the 🗞️ during #AntimicrobialResistance Week 💊🦠 with 👨‍🏫 @kasim_allel

[Antimicrobial Resistance Research Team | CNPI @AMR_CNPI]

The challenge is based on innovative re-use of surveillance data, and the team, led by @kasim_allel, developed a spatiotemporal modelling framework using generalised additive models for analysing AMR dynamics and identifying key change points in Europe from 2004-2022 🌎

[Kasim Allel @kasim_allel]

Thrilled about the substantial collaborative effort with the HERC team. We propose early detection of change points in AMR incidence, exemplified as early warning systems.
#antimicrobialresistance #vivli #Oxford @Oxford_NDPH

https://t.co/Pryd4dvTPN

[Vivli @VivliCenter]

We're delighted to announce the awardees of the Vivli Antimicrobial Resistance (AMR) Surveillance Open Data Re-Use Data Challenge! With a total of 56 teams from 27 different countries participating, we recognize seven outstanding teams. Learn more here: https://t.co/gok2urVJly

[Economics of Population Health Research Centre @EPH_Oxford]

NEW PUBLICATION

Excess burden of antibiotic-resistant bloodstream infections: evidence from a multicentre retrospective cohort study in Chile, 2018–2022

@kasim_allel @kb_pouwels

1/4
https://t.co/G7xtX2bTVN

[LSHTM TB Centre @LSHTM_TB]

#PLOSGlobalPublicHealth: Systematic review of the economic impact of novel Mycobacterium tuberculosis specifi ... https://t.co/jOy3L8Q9uO

[Ineos Oxford Institute for Antimicrobial Research @IneosOxford]

📢 We are delighted to announce the launch of the Oxford AMR Network!

The Oxford AMR Network harnesses @UniofOxford's expertise in life, medical and social sciences to tackle the antibiotic challenge threatening modern medicine.

Find out more here👉https://t.co/FG0coqN1uZ

[Economics of Population Health Research Centre @EPH_Oxford]

NEW PUBLICATION

Fatal journeys: causes of death in international travellers in South America

@kasim_allel

#America #CommunicableDiseases #injuries #migrant #mortality #Noncommunicable #prevention #travel

https://t.co/fclbgVGQVn

[The Fleming Fund @FlemingFund]

Without urgent #ActionOnAMR, antimicrobial resistance will account for three deaths every minute between 2025 and 2050⏰

The latest #GRAM paper in @TheLancet
has new historical estimates and the world’s first forecasts on the global #AMR burden⬇️

https://t.co/0E2rLjKW8V

[The Lancet @TheLancet]

🆕 Antimicrobial resistance poses an important global health challenge in the 21st century.

A new in-depth global analysis suggests more than 39 million deaths from antibiotic-resistant infections could occur between now & 2050.

Explore the data: https://t.co/MWXNRrUDuz #AMR

[Prof. Dame Sally Davies @UKAMREnvoy]

New data released today in @TheLancet shows that without urgent action, antimicrobial resistance could kill 39 million people by 2050.

Deaths and inequities from the global antibiotic emergency are increasing and now is the time to take urgent action.

https://t.co/O91bRl2G91

[Kasim Allel @kasim_allel]

@QuentinLclrc @LeCnam @MESuRS_Cnam Congrats Quentin!! all the bests!

[Economics of Population Health Research Centre @EPH_Oxford]

HERC ARE RECRUITING

We are hiring a Researcher in Health Choice Modelling (Grade 6).

The closing date for applications is noon, on Monday 23rd September 2024.

https://t.co/3xgPpbCgSr

[LSHTM Open Research @LSHTMopen]

🔓New #PhD thesis live on Research Online!

Impacts of antimicrobial resistance bloodstream infections among hospital patients and potential interventions: a case study in Chile - @kasim_allel

https://t.co/eHUSjem4tR

#OpenAccess #Chile #InfectiousDiseases #PublicHealth

[One Health Trust @OneHealthTrust]

In this episode of #OWOH as @kasim_allel of @LSHTM_AMR explains that AMR is worsened in poorer countries by poor sanitation, lack of healthcare, and antibiotic use in livestock, necessitating more comprehensive government action.

Tune in: https://t.co/mCcdlNaGtp

#AMR #OneHealth

[School of Health & Medical Sciences @CityStG_Health]

In the new @TheLancet Series on antimicrobial resistance (AMR), St George's Professor Mike Sharland and colleagues propose new global targets to reduce AMR-linked deaths and improve access to essential antibiotics.

Read more: https://t.co/fpCvpCUXVf

@AMR_CNPI

[Economics of Population Health Research Centre @EPH_Oxford]

UPCOMING HERC SEMINAR

The History of Health Economics

Thursday 27 June, 11:00 hours (11.00 am UK BST)

@Oxford_NDPH @pmc868

#healtheconomics #HealthPolicy #EconTwitter #EconomicEvaluation #QALYs

Free event, requires registration: https://t.co/qYK4RttpjY

[Kasim Allel @kasim_allel]

Thanks to the @LSHTM_AMR and my colleagues for such a rewarding experience😊😊! #AMR
https://t.co/txhBdfUe5i

[Kasim Allel @kasim_allel]

@Cris_Monteneg @KingsCollegeLon @GHSMatKCL @wcceh @UniofExeter Mil felicidades Cris! Avísame cuando andes por acá y nos vemos sin falta 🤩